Outcomes of hypertrophic obstructive cardiomyopathy patients undergoing alcohol septal ablation with a standard 3 mL dose of ethanol: Focus on long‐term safety
- 30 September 2019
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 95 (6) , 1212-1218
Abstract
Objectives: The objective of this research was to assess the long‐term results of alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy (HOCM), with all of them receiving a standard 3 mL ethanol dose.Background: Generally, ethanol (0.5–3 mL) is infused depending on a septal artery width or interventricular septum (IVS) thickness during alcohol septal ablation. We injected 3 mL of ethanol irrespective of IVS thickness or perforator width in all cases.Methods: Between 2000 and 2017, 150 HOCM patients (78 males, 72 females) underwent alcohol septal ablation procedures. In all cases we intentionally used the constant dose of ethanol (3 mL). The median of age was 52 (interquartile range: 41–60) years.Results: The median of follow‐up was 71 (interquartile range: 36–110) months. Hospital mortality was 0.67% (one patient died of sepsis). Perioperative high‐grade atrioventricular blocks required permanent pacemaker implantations—18 (12%). Long‐term survival rates were as follows: 95.1% (95% confidence interval [CI]: 92.7–97.5%), 85.8% (95% CI: 83.7–87.0%), and 81.7% (95% CI: 79.7–83.7%) at 5‐, 10‐, and 15‐year follow‐up, respectively. One‐sample log‐rank test revealed no significant differences in 15‐year survival rates between the alcohol septal ablation cohort and age‐ and sex‐matched Russian population.Conclusions: Alcohol septal ablation with the standard (3 mL) ethanol dose is safe and efficient. Survival rates after alcohol septal ablation are comparable with those in age‐ and sex‐matched general Russian population.Keywords
This publication has 15 references indexed in Scilit:
- Obstruction after alcohol septal ablation is associated with cardiovascular mortality eventsHeart, 2016
- Contemporary techniques for catheter-based intervention for hypertrophic obstructive cardiomyopathyEuroIntervention, 2016
- Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registryEuropean Heart Journal, 2016
- Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart blockInternational Journal of Cardiology, 2014
- Survival After Alcohol Septal Ablation for Obstructive Hypertrophic CardiomyopathyCirculation, 2012
- Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 YearsCanadian Journal of Cardiology, 2011
- Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive CardiomyopathyJACC, 2011
- Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effectiveHeart and Vessels, 2009
- Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experienceClinical Research in Cardiology, 2007
- Comparing Survival of a Sample to That of a Standard PopulationJNCI: Journal of the National Cancer Institute, 2003